{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:29:45Z","timestamp":1794000585929,"version":"4.8.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28922","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T17:51:45Z","timestamp":1711907505000},"page":"e28922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives"],"prefix":"10.1016","volume":"10","author":[{"given":"Dhirendra","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randhir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9007-0437","authenticated-orcid":false,"given":"Abidemi James","family":"Akindele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl B","key":"10.1016\/j.heliyon.2024.e28922_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/eurheartj\/14.suppl_B.48","article-title":"Safety profile of an anti-anginal agent with potassium channel opening activity: an overview","volume":"14","author":"Roland","year":"1993","journal-title":"Eur. Heart J."},{"issue":"38","key":"10.1016\/j.heliyon.2024.e28922_bib2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","year":"2013","journal-title":"Eur. Heart J."},{"issue":"Suppl B","key":"10.1016\/j.heliyon.2024.e28922_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/eurheartj\/14.suppl_B.48","article-title":"Safety profile of an anti-anginal agent with potassium channel opening activity: an overview","volume":"14","author":"Roland","year":"1993","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1253\/circj.CJ-09-0649","article-title":"Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study","volume":"74","author":"Horinaka","year":"2010","journal-title":"Circ. J. : official journal of the Japanese Circulation Society"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28922_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/14656566.2.5.845","article-title":"The role of nicorandil in the treatment of myocardial ischaemia","volume":"2","author":"Falase","year":"2001","journal-title":"Expet Opin. Pharmacother."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e28922_bib7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.2169\/internalmedicine.8516-16","article-title":"Nicorandil was an effective treatment option for a patient with bland-white-garland syndrome","volume":"56","author":"Morishita","year":"2017","journal-title":"Intern. Med. (Tokyo)"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00005344-200006000-00014","article-title":"Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism","volume":"35","author":"Nakae","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e28922_bib9","doi-asserted-by":"crossref","first-page":"18J","DOI":"10.1016\/0002-9149(89)90200-2","article-title":"Nicorandil as a hybrid between nitrates and potassium channel activators","volume":"63","author":"Taira","year":"1989","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e28922_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1006\/jmcc.2000.1152","article-title":"Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning","volume":"32","author":"Nakano","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0735-1097(02)02268-4","article-title":"Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C","volume":"40","author":"Tsuchida","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1042\/bj2550855","article-title":"Cyclic GMP-dependent protein kinase stimulates the plasmalemmal Ca2+ pump of smooth muscle via phosphorylation of phosphatidylinositol","volume":"255","author":"Vrolix","year":"1988","journal-title":"Biochem. J."},{"issue":"Suppl 3","key":"10.1016\/j.heliyon.2024.e28922_bib13","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00005344-199206203-00008","article-title":"Pharmacokinetic profile of nicorandil in humans: an overview","volume":"20","author":"Frydman","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e28922_bib14","doi-asserted-by":"crossref","first-page":"25J","DOI":"10.1016\/0002-9149(89)90201-4","article-title":"Pharmacokinetics of nicorandil","volume":"63","author":"Frydman","year":"1989","journal-title":"Am. J. Cardiol."},{"issue":"Suppl 3","key":"10.1016\/j.heliyon.2024.e28922_bib15","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00005344-199206203-00015","article-title":"Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy","volume":"20","author":"Wagner","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00878678","article-title":"Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers","volume":"9","author":"Kool","year":"1995","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000089603","article-title":"Nicorandil \u2013 \u201creview of pharmacological properties and clinical applications\u201d","volume":"5","author":"Schmid","year":"2005","journal-title":"Heart Drug"},{"key":"10.1016\/j.heliyon.2024.e28922_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/ATVBAHA.115.305380","article-title":"Atherosclerosis","volume":"35","author":"Lu","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28922_bib20","first-page":"1156","article-title":"Chemistry and pharmacology of plant cardioprotectives: a review","volume":"2","author":"Arya","year":"2011","journal-title":"IJPSR"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/bcpt.12078","article-title":"Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats","volume":"113","author":"Abdel-Raheem","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28922_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4196\/kjpp.2019.23.1.37","article-title":"Nicorandil alleviated cardiac hypoxia\/reoxygenation-induced cytotoxicity via upregulating ketone body metabolism and ACAT1 activity","volume":"23","author":"Bai","year":"2019","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.arcmed.2018.12.006","article-title":"Protective effects of nicorandil on cardiac function and left ventricular remodeling in a rat model of ischemic heart failure","volume":"49","author":"Xing","year":"2018","journal-title":"Arch. Med. Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28922_bib24","first-page":"591","article-title":"Nicorandil pretreatment inhibits myocardial apoptosis and improves cardiac function after coronary microembolization in rats","volume":"15","author":"He","year":"2018","journal-title":"Journal of geriatric cardiology : JGC"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib25","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ajem.2017.02.051","article-title":"Cardioprotective effect of nicorandil against myocardial injury following cardiac arrest in swine","volume":"35","author":"Liang","year":"2017","journal-title":"Am. J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172803","article-title":"Doxorubicin-induced oxidative stress: the protective effect of nicorandil on HL-1 cardiomyocytes","volume":"12","author":"Asensio-L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e28922_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vph.2016.12.004","article-title":"Vascular calcification abrogates the nicorandil mediated cardio-protection in ischemia reperfusion injury of rat heart","volume":"89","author":"Ravindran","year":"2017","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1074248416636477","article-title":"Nicorandil, a nitric oxide donor and ATP-sensitive potassium channel opener, protects against dystrophin-deficient cardiomyopathy","volume":"21","author":"Afzal","year":"2016","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00424-015-1763-8","article-title":"Nicorandil stimulates a Na\u207a\/Ca2\u207a exchanger by activating guanylate cyclase in Guinea pig cardiac myocytes","volume":"468","author":"Wei","year":"2016","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib30","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3892\/etm.2015.2782","article-title":"Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia\/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats","volume":"10","author":"Li","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib31","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1159\/000374035","article-title":"Nicorandil protects the heart from ischemia\/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through PI3K\/akt signaling pathway","volume":"35","author":"Wu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e28922_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000360008","article-title":"GATA-4 transcription factor regulates cardiac COX-2 expression induced by nicorandil in left ventricle of rats","volume":"93","author":"Serizawa","year":"2014","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28922_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1440-1681.12185","article-title":"Nicorandil improves electrical remodelling, leading to the prevention of electrically induced ventricular tachyarrhythmia in a mouse model of desmin-related cardiomyopathy","volume":"41","author":"Matsushita","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018922","article-title":"Cardioprotective effect of nicorandil, a mitochondrial ATP-sensitive potassium channel opener, prolongs survival in HSPB5 R120G transgenic mice","volume":"6","author":"Sanbe","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1536\/ihj.53.139","article-title":"Cardioprotective effects of sarcolemmal and mitochondrial K-ATP channel openers in an experimental model of autoimmune myocarditis. Role of the reduction in calcium overload during acute heart failure","volume":"53","author":"Niwano","year":"2012","journal-title":"Int. Heart J."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e28922_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000323555","article-title":"Nicorandil inhibits angiotensin-II-induced proliferation of cultured rat cardiac fibroblasts","volume":"87","author":"Liou","year":"2011","journal-title":"Pharmacology"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28922_bib37","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1440-1681.2009.05174.x","article-title":"Effects of chronic treatment with a low dose of nicorandil on the function of the rat aorta during ageing","volume":"36","author":"Raveaud","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e28922_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejphar.2007.10.026","article-title":"p38-MAPK is involved in restoration of the lost protection of preconditioning by nicorandil in vivo","volume":"579","author":"Iliodromitis","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.yjmcc.2006.01.020","article-title":"Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis","volume":"40","author":"Nishikawa","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e28922_bib40","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1253\/circj.70.1650","article-title":"Nicorandil improves post-ischemic myocardial dysfunction in association with opening the mitochondrial K(ATP) channels and decreasing hydroxyl radicals in isolated rat hearts","volume":"70","author":"Lu","year":"2006","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1191\/0269216306pf858oa","article-title":"Myocardial protective effects of nicorandil, an opener of potassium channels on senile rat heart","volume":"21","author":"Liu","year":"2006","journal-title":"Perfusion"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejcts.2006.04.033","article-title":"Contractile recovery of heart muscle after hypothermic hypoxia is improved by nicorandil via mitochondrial K(ATP) channels","volume":"30","author":"Steensrud","year":"2006","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0735-1097(99)00552-5","article-title":"Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels","volume":"35","author":"Sato","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28922_bib44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.lfs.2004.12.042","article-title":"Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia\/reperfusion in the intact anesthetized rabbit model?","volume":"77","author":"Das","year":"2005","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib45","first-page":"157","article-title":"Zhongguo wei zhong bing ji jiu yi xue","volume":"17","author":"Feng","year":"2005","journal-title":"Chin. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00210-003-0851-z","article-title":"Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart","volume":"369","author":"Ishida","year":"2004","journal-title":"N. Schmied. Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib47","doi-asserted-by":"crossref","first-page":"H1273","DOI":"10.1152\/ajpheart.01055.2003","article-title":"Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits","volume":"286","author":"Tang","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1043-6618(02)00335-3","article-title":"Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia\/reperfusion: a study in an intact anesthetized rabbit model","volume":"47","author":"Das","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28922_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0008-6363(01)00556-9","article-title":"Noninvasive assessment of the effects of nicorandil on left ventricular volumes and function in reperfused myocardial infarction","volume":"54","author":"Watzinger","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0735-1097(02)02007-7","article-title":"Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes","volume":"40","author":"Akao","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib51","doi-asserted-by":"crossref","first-page":"59 99347","DOI":"10.18632\/oncotarget.19966","article-title":"Effects of nicorandil on PI3K\/Akt signaling pathway and its anti-apoptotic mechanisms in coronary microembolization in rats","volume":"8","author":"Su","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib52","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1111\/jcmm.14413","article-title":"Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K\/Akt pathway","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib53","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/jcmm.13130","article-title":"Nicorandil regulates the macrophage skewing and ameliorates myofibroblasts by inhibition of RhoA\/Rho-kinase signalling in infarcted rats","volume":"22","author":"Lee","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bcp.2015.10.004","article-title":"Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats","volume":"98","author":"Mohamed","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/MSMBR.910974","article-title":"Myocardial protective effects of nicorandil on rats with Type 2 diabetic cardiomyopathy","volume":"24","author":"Zhang","year":"2018","journal-title":"Medical science monitor basic research"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28922_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044485","article-title":"Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension","volume":"7","author":"Zuo","year":"2012","journal-title":"PLoS One"},{"issue":"62","key":"10.1016\/j.heliyon.2024.e28922_bib57","article-title":"Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats","volume":"15","author":"Zhang","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib58","first-page":"2924","article-title":"Cardioprotective effects of nicorandil on coronary heart disease patients undergoing elective percutaneous coronary intervention","volume":"23","author":"Pang","year":"2017","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e28922_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026232","article-title":"Effects of nicorandil administration on infarct size in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the CHANGE trial","volume":"11","author":"Qian","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5152\/akd.2014.5207","article-title":"Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention","volume":"15","author":"Yang","year":"2015","journal-title":"Anatol. J. Cardiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28922_bib61","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/joic.12142","article-title":"Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention","volume":"27","author":"Shehata","year":"2014","journal-title":"J. Intervent. Cardiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib62","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.jvca.2008.02.011","article-title":"Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery","volume":"22","author":"Yamamoto","year":"2008","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib63","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/FJC.0b013e318163a95f","article-title":"Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease","volume":"51","author":"Ishibashi","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diacare.29.02.06.dc05-1588","article-title":"Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia","volume":"29","author":"Ishii","year":"2006","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e28922_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078231","article-title":"Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib66","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00259-004-1672-0","article-title":"Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction","volume":"32","author":"Kasama","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1253\/circj.66.317","article-title":"Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty","volume":"66","author":"Sakai","year":"2002","journal-title":"Circ. J. : official journal of the Japanese Circulation Society"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib68","first-page":"3095","article-title":"Nicorandil effects on platelet function, Hs-CRP, MMP-9 and myocardial antioxidation in patients with unstable angina","volume":"18","author":"Peng","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.shk.0000168874.83401.3f","article-title":"Nicorandil attenuates NF-kappaB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery","volume":"24","author":"Kawamura","year":"2005","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib70","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1111\/jcmm.15169","article-title":"Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention","volume":"24","author":"Hu","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28922_bib71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jss.2009.09.049","article-title":"The effect of nicorandil on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model","volume":"167","author":"Yamazaki","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.heliyon.2024.e28922_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2014.12.017","article-title":"Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats","volume":"748","author":"Elshazly","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib73","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08923973.2020.1830104","article-title":"Nicorandil and atorvastatin attenuate carbon tetrachloride - induced liver fibrosis in rats","volume":"42","author":"Abdel-Sattar","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib74","article-title":"Amelioration of doxorubicin- Induced liver and kidney toxicities by nicorandil alone and co-administered with prednisolone and diltiazem","volume":"12","author":"Akindele","year":"2020","journal-title":"Proceedings of the Nigerian Academy of Science"},{"key":"10.1016\/j.heliyon.2024.e28922_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lfs.2019.02.057","article-title":"Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats","volume":"222","author":"Soliman","year":"2019","journal-title":"Life Sci."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e28922_bib76","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejps.2013.08.004","article-title":"Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension","volume":"50","author":"Lee","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci. : official journal of the European Federation for Pharmaceutical Sciences"},{"key":"10.1016\/j.heliyon.2024.e28922_bib77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.etap.2018.03.012","article-title":"Nicorandil alleviates ovalbumin-induced airway inflammation in a mouse model of asthma","volume":"59","author":"El-Kashef","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.intimp.2018.09.017","article-title":"Nicorandil ameliorates pulmonary inflammation and fibrosis in a rat model of silicosis","volume":"64","author":"El-Kashef","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2024.e28922_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117423","article-title":"Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1\u03b1 levels","volume":"246","author":"Kseibati","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib80","first-page":"725","article-title":"Protective effect of nicorandil on collapse-induced lung injury in rabbits by inhibiting apoptosis","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e28922_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4957646","article-title":"Nicorandil attenuates LPS-induced acute lung injury by pulmonary endothelial cell protection via NF-\u03baB and MAPK pathways","volume":"2019","author":"He","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib82","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3892\/mmr.2013.1255","article-title":"Protective effect of nicorandil on hypoxia-induced apoptosis in HPAECs through inhibition of p38 MAPK phosphorylation","volume":"7","author":"Yu","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib83","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1139\/cjpp-2020-0012","article-title":"Nicorandil prevents the nephrotoxic effect of cyclosporine-A in albino rats through modulation of HIF-1\u03b1\/VEGF\/eNOS signaling","volume":"99","author":"Harb","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib84","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4149\/gpb_2019034","article-title":"Effects of nicorandil on vascular and renal dysfunctions in adenine-induced nephropathy: possible underlying mechanisms","volume":"38","author":"Hussein","year":"2019","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.heliyon.2024.e28922_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108777","article-title":"Nicorandil combats doxorubicin-induced nephrotoxicity via amendment of TLR4\/P38 MAPK\/NF\u03ba-B signaling pathway","volume":"311","author":"Khames","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e28922_bib86","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.kjms.2017.03.003","article-title":"Effects of nicorandil on renal function and histopathology in rats with partial unilateral ureteral obstruction","volume":"33","author":"Ozturk","year":"2017","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib87","doi-asserted-by":"crossref","first-page":"F339","DOI":"10.1152\/ajprenal.00158.2012","article-title":"Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages","volume":"303","author":"Tamura","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib88","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1476-5381.2011.01231.x","article-title":"Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney","volume":"163","author":"Shimizu","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28922_bib89","doi-asserted-by":"crossref","first-page":"F1151","DOI":"10.1152\/ajprenal.00596.2011","article-title":"Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse","volume":"302","author":"Tanabe","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib90","doi-asserted-by":"crossref","first-page":"F339","DOI":"10.1152\/ajprenal.00158.2012","article-title":"Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages","volume":"303","author":"Tamura","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib91","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2015.05.078","article-title":"Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function","volume":"195","author":"Nawa","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28922_bib92","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s00380-016-0809-y","article-title":"Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization","volume":"31","author":"Fan","year":"2016","journal-title":"Heart Ves."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0003319719841733","article-title":"Preventive effects of nicorandil against contrast-induced nephropathy in patients with moderate renal insufficiency undergoing percutaneous coronary intervention","volume":"71","author":"Zhang","year":"2020","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib94","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/imj.13962","article-title":"Preventive effect of nicorandil on contrast-induced nephropathy: a meta-analysis of randomised controlled trials","volume":"48","author":"Li","year":"2018","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.heliyon.2024.e28922_bib95","first-page":"14 11837","article-title":"Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28922_bib96","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.023","article-title":"Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia","volume":"25","author":"Gupta","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.heliyon.2024.e28922_bib97","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jns.2019.05.007","article-title":"Corrigendum to \"Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K\/Akt1 pathway in a mouse model of deep hypothermic low flow","volume":"403","author":"Yu","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00540-018-2471-2","article-title":"Nicorandil increased the cerebral blood flow via nitric oxide pathway and ATP-sensitive potassium channel opening in mice","volume":"32","author":"Kotoda","year":"2018","journal-title":"J. Anesth."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e28922_bib99","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000351247","article-title":"Effects of nicorandil in neuroprotective activation of PI3K\/AKT pathways in a cellular model of Alzheimer's disease","volume":"70","author":"Kong","year":"2013","journal-title":"Eur. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e28922_bib100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2015.07.010","article-title":"Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K\/Akt1 pathway in a mouse model of deep hypothermic low flow","volume":"357","author":"Yu","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28922_bib101","first-page":"95","article-title":"Neuroprotective effects of potassium channel openers on cerebral ischemia\u2013reperfusion injury in diabetic rats","volume":"55","author":"Pithadia","year":"2017","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"10.1016\/j.heliyon.2024.e28922_bib102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12038-020-0021-1","article-title":"Effects of nicorandil on neurobehavioral function, BBB integrity, edema and stereological parameters of the brain in the sub-acute phase of stroke in a rat model","volume":"45","author":"Owjfard","year":"2020","journal-title":"J. Biosci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/187152808785748164","article-title":"Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease?","volume":"7","author":"Hosseini-Tabatabaei","year":"2008","journal-title":"Inflamm. Allergy - Drug Targets"},{"issue":"1 60","key":"10.1016\/j.heliyon.2024.e28922_bib104","article-title":"Potential role of microRNA-7 in the anti-neuroinflammation effects of nicorandil in astrocytes induced by oxygen-glucose deprivation","volume":"13","author":"Dong","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e28922_bib105","first-page":"74","article-title":"Benefit of nicorandil using an immunologic murine model of experimental colitis","volume":"4","author":"Hosseini-Tabatabaei","year":"2009","journal-title":"Cent. Eur. J. Biol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/srep14043","article-title":"Role of the KATP channel in the protective effect of nicorandil on cyclophosphamide-induced lung and testicular toxicity in rats","volume":"5","author":"Ahmed","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e28922_bib107","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00210-020-01854-w","article-title":"Ameliorative effect of nicorandil in ovarian ischemia-reperfusion-induced injury in rats: role of potassium channel","volume":"393","author":"Abdel-Gaber","year":"2020","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib108","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2015.10.047","article-title":"Opioid pathways activation mediates the activity of nicorandil in experimental models of nociceptive and inflammatory pain","volume":"768","author":"Dutra","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib109","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2018.02.014","article-title":"Nicorandil inhibits mechanical allodynia induced by paclitaxel by activating opioidergic and serotonergic mechanisms","volume":"824","author":"Morais","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e28922_bib110","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.3892\/mmr.2020.11546","article-title":"Effects of nicorandil on p120 expression in the spinal cord and dorsal root ganglion of rats with chronic postsurgical pain","volume":"22","author":"Huang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e28922_bib111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2017.06.019","article-title":"Nicorandil modulated macrophages activation and polarization via NF-\u03bab signaling pathway","volume":"88","author":"Zhang","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib112","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2018.01.009","article-title":"Nicorandil and theophylline can protect experimental rats against complete Freund's adjuvant-induced rheumatoid arthritis through modulation of JAK\/STAT\/RANKL signaling pathway","volume":"822","author":"Gaafar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib113","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lfs.2019.01.002","article-title":"Nicorandil abates arthritic perturbations induced by complete Freund's adjuvant in rats via conquering TLR4-MyD88-TRAF6 signaling pathway","volume":"218","author":"Saad","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e28922_bib114","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2015.11.034","article-title":"Nicorandil inhibits neutrophil recruitment in carrageenan-induced experimental pleurisy in mice","volume":"769","author":"Matsui","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1253\/circj.CJ-08-0843","article-title":"Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production","volume":"73","author":"Eguchi","year":"2009","journal-title":"Circ. J. : official journal of the Japanese Circulation Society"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib116","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jphs.2014.12.017","article-title":"Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation","volume":"127","author":"Aizawa","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2024.e28922_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110121","article-title":"Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K\/Akt\/eNOS pathway","volume":"127","author":"Zhan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e28922_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172542","article-title":"Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis","volume":"859","author":"Chen","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib119","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00232-020-00129-y","article-title":"Nicorandil affects mitochondrial respiratory chain function by increasing complex III activity and ROS production in skeletal muscle mitochondria","volume":"253","author":"S\u00e1nchez-Duarte","year":"2020","journal-title":"J. Membr. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e28922_bib120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00232-020-00129-y","article-title":"Nicorandil affects mitochondrial respiratory chain function by increasing complex III activity and ROS production in skeletal muscle mitochondria","volume":"253","author":"S\u00e1nchez-Duarte","year":"2020","journal-title":"J. Membr. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib121","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12010-008-8384-z","article-title":"Gastroprotective effect of nicorandil in indomethacin and alcohol-induced acute ulcers","volume":"152","author":"El-Moselhy","year":"2009","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e28922_bib122","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000056127","article-title":"Evaluation of the effects of nicorandil on experimentally induced gastric ulcers","volume":"63","author":"Patel","year":"2001","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e28922_bib123","doi-asserted-by":"crossref","first-page":"60","DOI":"10.31083\/ph.2007.1.6562","article-title":"Insights in the mechanisms underlying the anti-ulcer activity of nicorandil","volume":"62","author":"Ismail","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/j.heliyon.2024.e28922_bib124","first-page":"59","article-title":"Gastric mucosal protective action of nicorandil against gastric lesions induced by indomethacin","volume":"vol. 28","author":"Abdel-Hakim","year":"2008"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e28922_bib125","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1007\/s10620-011-1623-0","article-title":"The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model","volume":"56","author":"Suto","year":"2011","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e28922_bib126","first-page":"725","article-title":"Protective effect of nicorandil on collapse-induced lung injury in rabbits by inhibiting apoptosis","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e28922_bib127","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/1440-1681.13395","article-title":"Hypothesis: the potential therapeutic role of nicorandil in COVID-19","volume":"47","author":"Ashour","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.heliyon.2024.e28922_bib128","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s13287-021-02482-8","article-title":"Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction","volume":"12","author":"Safari","year":"2021","journal-title":"Stem Cell Res. Ther."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024049533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024049533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:17:16Z","timestamp":1784207836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024049533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024049533"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28922","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28922"}}